WS Byun, ES Bae, WK Kim, SK Lee - Journal of Natural Products, 2022 - ACS Publications
Alkaloids derived from natural products have been traditionally used to treat various diseases, including cancers. Rutaecarpine (1), a β-carboline-type alkaloid obtained from …
Although docetaxel-based regimens are common and effective for early-stage triple- negative breast cancer (TNBC) treatment, acquired drug resistance frequently occurs …
JJ Mandumpala, S Baby, AA Tom, C Godugu… - Life sciences, 2022 - Elsevier
Triple-negative breast cancer (TNBC) is a particularly lethal subtype of breast cancer owing to its heterogeneity, high drug resistance, poor prognosis and lack of therapeutic targets …
SK Park, WS Byun, S Lee, YT Han, YS Jeong… - Biochemical …, 2020 - Elsevier
Triple-negative breast cancer (TNBC) is the most aggressive type of breast cancer, characterized by the lack of expression of estrogen receptor, progesterone receptor, and …
Colorectal cancer (CRC) is a common and intractable malignancy with a high mortality risk. Conventional chemotherapeutics are effective for patients with early stage CRC, but the …
HJ Han, WS Byun, GH Lee, WK Kim, K Jang… - Bioorganic & medicinal …, 2021 - Elsevier
Disruptor of telomeric silencing-1 like (DOT1L) is a histone H3 methyltransferase which specifically catalyzes the methylation of histone H3 lysine-79 residue. Recent findings …
P Li, Z Zhang, P Sun - Journal of Cancer, 2024 - ncbi.nlm.nih.gov
To assess telomere silencing 1-like (DOTIL) gene expression within gastric cancer (GC) tissues as well as its function of promoting cancer stem cell (CSC)-mediated epithelial …
Background: Triple-Negative Breast Cancer (TNBC) is the most aggressive form of Breast Cancer (BC), with high rates of metastasis and recurrence and limited treatment options …
WS Byun, GH Lee, H Park, SK Lee - Pharmaceuticals, 2020 - mdpi.com
Due to a lack of hormone receptors, current treatment strategies for triple-negative breast cancer (TNBC) are limited with frequent disease recurrence and metastasis. Recent findings …